Further, elevated serum expression of HOTAIR in AD patients has been reported to elicit close associations with the severity of cognitive and memory impairments (Lu et al. 2022b), encouraging the proposition of serum HOTAIR levels as a biomarker for cognitive decline in AD. This evidence concerns the gene HOTAIR and Alzheimer disease.